Related references
Note: Only part of the references are listed.Association Study between Cervical Lesions and Single or Multiple Vaccine-Target and Non-Vaccine Target Human Papillomavirus (HPV) Types in Women from Northeastern Brazil
Barbara Simas Chagas et al.
PLOS ONE (2015)
A portrait of single and multiple HPV type infections in Brazilian women of different age strata with squamous or glandular cervical lesions
Leandro Santos de Araujo Resende et al.
BMC INFECTIOUS DISEASES (2014)
Prevalence and risk factors for cervical neoplasia: a cervical cancer screening program in Beijing
Lixin Tao et al.
BMC PUBLIC HEALTH (2014)
Assessment of herd immunity and cross-protection after a human papillomavirus vaccination programme in Australia: a repeat cross-sectional study
Sepehr N. Tabrizi et al.
LANCET INFECTIOUS DISEASES (2014)
Efficacy of the HPV-16/18 vaccine: Final according to protocol results from the blinded phase of the randomized Costa Rica HPV-16/18 vaccine trial
Allan Hildesheim et al.
VACCINE (2014)
Replication interference between human papillomavirus types 16 and 18 mediated by heterologous E1 helicases
Seiichiro Mori et al.
VIROLOGY JOURNAL (2014)
Quadrivalent HPV vaccine efficacy against disease related to vaccine and non-vaccine HPV types in males
Stephen E. Goldstone et al.
VACCINE (2013)
Socio-Demographic and Behavioural Risk Factors for Cervical Cancer and Knowledge, Attitude and Practice in Rural and Urban Areas of North Bengal, India
Sreejata Raychaudhuri et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2012)
Human papillomavirus types in 115,789 HPV-positive women: A meta-analysis from cervical infection to cancer
Peng Guan et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Evolutionary Ecology of Human Papillomavirus: Trade-offs, Coexistence, and Origins of High-Risk and Low-Risk Types
Paul A. Orlando et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial
Matti Lehtinen et al.
LANCET ONCOLOGY (2012)
Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial
Cosette M. Wheeler et al.
LANCET ONCOLOGY (2012)
Human Papillomavirus Infection with Multiple Types: Pattern of Coinfection and Risk of Cervical Disease
Anil K. Chaturvedi et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Antibodies from women immunized with Gardasil® cross-neutralize HPV 45 pseudovirions
Judith F. Smith et al.
HUMAN VACCINES (2007)
Association between HLA-DRB1 polymorphism, high-risk HPV infection and cervical neoplasia in southern Chinese
Paul K. S. Chan et al.
JOURNAL OF MEDICAL VIROLOGY (2007)
HLA-B alleles, high-risk HPV infection and risk for cervical neoplasia in southern Chinese women
PKS Chan et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Risk association between human leukocyte antigen - A allele and high-risk human papillomavirus infection for cervical neoplasia in Chinese women
DPC Chan et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Prevalence and clustering patterns of human papillomavirus genotypes in multiple infections
AK Chaturvedi et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2005)
Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica
R Herrero et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Detection and typing of human papillomavirus by E6 nested multiplex PCR
K Sotlar et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2004)
Share Paper
